The impacts of interferon (IFN) signaling on COVID-19 pathology are multiple, with both
protective and harmful effects being documented. We report here a multiomics investigation of …

Myeloid-derived suppressor cells are increased in the peripheral blood of advanced-stage
cancer patients; however, no studies have shown a correlation of these immunosuppressive …

Background Immune checkpoint inhibitors have improved overall survival rates for many
cancers, yet the majority of patients do not respond to treatment and succumb to disease …

One approach to enhancing the T cell response to tumors is vaccination with mimotopes,
mimics of tumor epitopes. While mimotopes can stimulate proliferation of T cells that recognize …

We sought to identify tumor-secreted factors that altered the frequency of MDSCs and
correlated with clinical outcomes in advanced melanoma patients. We focused our study on …

Myeloid-derived suppressor cells (MDSCs) are a heterogeneous population of myeloid cells
that are increased in the peripheral blood of cancer patients and limit productive immune …

People with Down syndrome (DS; trisomy 21) display a different disease spectrum relative to
the general population, including lower rates of solid malignancies and higher incidence of …

COVID19 is a heterogeneous medical condition involving diverse underlying
pathophysiological processes including hyperinflammation, endothelial damage, thrombotic …

Peptide vaccines enhance the response of T cells toward tumor antigens and represent a
strategy to augment antigen-independent immunotherapies of cancer. However, peptide …

Purpose: A phase Ib/II clinical trial was conducted to evaluate the safety and efficacy of the
combination of all-trans retinoic acid (ATRA) with pembrolizumab in patients with stage IV …